For research use only. We do not sell to patients.
IDO-IN-8
CAS No. : 1402837-77-7
Biological Activity：IDO-IN-8 (NLG-1487) is an indoleamine 2,3-dioxygenase (IDO) inhibitor extracted from patent WO WO2012142237A1, compound 1487, has an IC50 of 1-10 μM.
Research Area：Cancer
Targets：Indoleamine 2,3-Dioxygenase (IDO)
Related Screening Libraries:Bioactive Compound Library Plus;Immunology/Inflammation Compound Library;Metabolism/Protease Compound Library;Anti-Cancer Compound Library;Small Molecule Immuno-Oncology Compound Library;
Related Small Molecules:IDO1-IN-14;Coptisine Sulfate;Coptisine chloride;IACS-8968;Indoximod;IDO-IN-12;IDO1-IN-16;IDO-IN-14;(S)-Indoximod-d3;IDO1-IN-5;IDO1-IN-18;Palmatine;IDO1-IN-2;IDO5L;BMS-986242;IDO1-IN-12;IDO1/2-IN-1;GNF-PF-3777;Linrodostat;ZC0109;IDO1-IN-15;NLG802;NU223612;IDO1/TDO-IN-4;IDO1/TDO-IN-1;IDO1-IN-19
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
